Accueil
Mots-clés
Thésaurus mots-clés > Pathologies organiques > Pathologies digestives et métaboliques > HEPATITE
HEPATITESynonyme(s)VHC VHBVoir aussi : |
Documents disponibles dans cette catégorie (1395)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Chapitre
This paper provides an overview of the Canadian Community Epidemiological Network on Drug Use (CCENDU), which monitors drug use and adverse consequences of drug use at the community level. Recent findings from six reporting sites and national tr[...]Périodique
ESTEBAN J. I. ; SAULEDA S. ; QUER J. | 2008ENGLISH : The epidemic of hepatitis C virus (HCV) infection in Europe is continuously evolving and epidemiological parameters (prevalence, incidence, disease transmission patterns and genotype distribution) have changed substantially during th[...]Article : Périodique
M. MATICIC ; Z. PIRNAT ; A. LEICHT ; R. ZIMMERMANN ; T. WINDELINCK ; M. JAUFFRET-ROUSTIDE ; E. DUFFELL ; T. TAMMI ; E. SCHATZ |Background: People who inject drugs (PWID) account for the majority of new cases of hepatitis C virus (HCV) infection in Europe; however, HCV testing, and treatment for PWID remain suboptimal. With the advent of direct acting antivirals (DAAs) t[...]Périodique
SHEERIN I. G. ; F. T. GREEN ; J. D. SELLMAN | 2003ENGLISH : This paper estimates future health service costs of the current practice in New Zealand of not funding treatment of hepatitis C virus (HCV) infections. Costs are estimated separately for Maori and non-Maori, male and female IDUs. Mar[...]Périodique
L. COPELAND | 2004ENGLISH : The increasing health problem of hepatitis C virus infection has only recently attracted the attention of psychosocial research, especially among subjects at higher risk (e.g. injecting drug users). There is a lack of information abo[...]Article : Périodique
A. MATSER ; A. URBANUS ; R. B. GESKUS ; M. KRETZSCHMAR ; M. XIRIDOU ; M. BUSTER ; R. COUTINHO ; M. PRINS |AIMS: The hepatitis C virus (HCV) disease burden among injecting drug users (IDUs) is determined by HCV incidence, the long latency period of HCV, competing mortality causes, presence of co-infection and HCV treatment uptake. We examined the eff[...]Article : Périodique
D. HEDRICH ; P. ALVES ; M. FARRELL ; H. STÖVER ; L. MOLLER ; S. MAYET |AIMS: To review evidence on the effectiveness of opioid maintenance treatment (OMT) in prison and post-release. METHODS: Systematic review of experimental and observational studies of prisoners receiving OMT regarding treatment retention, opio[...]Périodique
S. MARS | 1997FRANÇAIS : Dans un rapport, la British Medical Association expose des propositions liées à la prise en charge des patients toxicomanes, notamment concernant le financement et ses problèmes, le rôle et l'implication du médecin généraliste, les p[...]Périodique
C. MATHEI ; G. ROBAEYS ; VAN RANST M. ; P. VAN DAMME ; BUNTINX F. | 2005ENGLISH : In industrialised countries, injecting drug use is currently the most important risk factor for infection with hepatitis C, resulting in high prevalence rates of hepatitis C among injecting drug users. To contain the hepatitis C epid[...]Périodique
CRISP B. R. ; J. G. BARBER ; R. GILBERTSON | 1997FRANÇAIS : Bien que ceux qui fournissent la drogue ou la seringue soient généralement les premiers à utiliser la seringue avant de la partager, des entretiens avec 32 utilisateurs australiens de drogue injectable ont décelé d'autres types de dr[...]Périodique
P. BOURGOIS ; PRINCE B. ; A. MOSS | 2004ENGLISH : A theoretical understanding of the gendered contours of structural, everyday, and symbolic violence suggests that young addicted women are particularly vulnerable to the infectious diseases caused by injection drug use-especially hep[...]Article : Périodique
J. BRUNEAU ; N. ARRUDA ; G. ZANG ; D. JUTRAS-ASWAD ; E. ROY |AIMS: To examine temporal trends in prescription opioid (PO) injection and to assess its association with hepatitis C virus (HCV) seroconversion among people who inject drugs (PWID). DESIGN: Prospective cohort study spanning 2004 to 2016. SET[...]Rapport
In 2008 Harm Reduction International released the Global State of Harm Reduction, a report that mapped responses to drug-related HIV and hepatitis C epidemics around the world for the first time. The report has since been published every two yea[...]Rapport
In 2008, Harm Reduction International released the Global State of Harm Reduction, a report that mapped responses to drug-related HIV and hepatitis C epidemics around the world for the first time. The data gathered for the report provided a crit[...]Rapport
The drive to scale-up needle and syringe programmes and opioid substitution therapy for people who inject drugs has stalled, according to this report. Despite a UN pledge to end AIDS by 2030, no new countries have established needle and syringe[...]